High fat diet feeding results in gender specific steatohepatitis and inflammasome activation

World Journal of Gastroenterology

Volumn , Issue 26, 2014, Pages 8525-8534

  Ganz, Michal ^a   Csak, Timea ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Gender differences; High fat diet; Inflammasome; Non alcoholic steatohepatitis

Indexed keywords

ABSENT IN MELANOMA 2; ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; INFLAMMASOME; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROCOLLAGEN; PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; MESSENGER RNA; NOD LIKE RECEPTOR 4; ACTA2 PROTEIN, MOUSE; ACTIN; AIM2 PROTEIN, MOUSE; AUTACOID; CCL2 PROTEIN, MOUSE; DNA BINDING PROTEIN; FRUCTOSE; GLUCOSE BLOOD LEVEL; IL1B PROTEIN, MOUSE; SUGAR INTAKE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; FATTY LIVER; FEMALE; GENDER; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID DIET; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ENZYME ACTIVITY; FEEDING; IMPAIRED GLUCOSE TOLERANCE; LIVER INJURY; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; LIVER; LIVER CIRRHOSIS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; SUGAR INTAKE; TIME; WEIGHT GAIN;

ACTINS; ALANINE TRANSAMINASE; ANIMALS; BLOOD GLUCOSE; CASPASE 1; CHEMOKINE CCL2; COLLAGEN TYPE I; DIET, HIGH-FAT; DIETARY SUCROSE; DNA-BINDING PROTEINS; FEMALE; FRUCTOSE; INFLAMMASOMES; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-1BETA; LIVER; LIVER CIRRHOSIS; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; PROCOLLAGEN; RNA, MESSENGER; SEX FACTORS; TIME FACTORS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 84904382730     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i26.8525     Document Type: Article

References (37)

1. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137-145 [PMID: 9005748] (Pubitemid 27058588)
2. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010; 5: 145-171 [PMID: 20078219 DOI: 10.1146/annurev-pathol-121808-102132]
3. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-967 [PMID: 12809815 DOI: 10.1111/j.1572-0241.2003.07486.x] (Pubitemid 36733754)
4. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 2008; 115: 141-150 [PMID: 18662168 DOI: 10.1042/CS20070402]
5. Ismail MH. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic. Am J Med Sci 2011; 341: 485-492 [PMID: 21412139 DOI: 10.1097/MAJ.0b013e3182018598]
6. Rahimi RS, Landaverde C. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. Nutr Clin Pract 2013; 28: 40-51 [PMID: 23286927 DOI: 10.1177/0884533612470464]
7. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, Takasaki K, Ludwig J. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002; 37: 154-160 [PMID: 12076877] (Pubitemid 34713069)
8. Sugimoto K, Takei Y. Clinicopathological features of nonalcoholic fatty liver disease. Hepatol Res 2011; 41: 911-920 [PMID: 21951869 DOI: 10.1111/j.1872-034X.2011.00867.x]
9. Tuyama AC, Chang CY. Non-alcoholic fatty liver disease. J Diabetes 2012; 4: 266-280 [PMID: 22564417 DOI: 10.1111/j.1753-0407.2012.00204.x]
10. Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol 2011; 46 Suppl 1: 63-69 [PMID: 20844903 DOI: 10.1007/s00535-010-0311-8]
11. Kashireddy PR, Rao MS. Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med (Maywood) 2004; 229: 158-162 [PMID: 14734794] (Pubitemid 38146559)
12. Spruss A, Henkel J, Kanuri G, Blank D, Püschel GP, Bischoff SC, Bergheim I. Female mice are more susceptible to non-alcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response. Mol Med 2012; 18: 1346-1355 [PMID: 22952059 DOI: 10.2119/molmed.2012.00223]
13. Kamada Y, Kiso S, Yoshida Y, Chatani N, Kizu T, Hamano M, Tsubakio M, Takemura T, Ezaki H, Hayashi N, Takehara T. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am J Physiol Gastrointest Liver Physiol 2011; 301: G1031-G1043 [PMID: 21885686 DOI: 10.1152/ajpgi.00211.2011]
14. Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012; 28: 137-161 [PMID: 22974247 DOI: 10.1146/annurev-cell-bio-101011-155745]
15. Ciraci C, Janczy JR, Sutterwala FS, Cassel SL. Control of innate and adaptive immunity by the inflammasome. Microbes Infect 2012; 14: 1263-1270 [PMID: 22841804 DOI: 10.1016/j.micinf.2012.07.007]
16. Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012; 143: 1158-1172 [PMID: 22982943 DOI: 10.1053/j.gastro.2012.09.008]
17. Sutterwala FS, Ogura Y, Flavell RA. The inflammasome in pathogen recognition and inflammation. J Leukoc Biol 2007; 82: 259-264 [PMID: 17470531 DOI: 10.1189/jlb.1206755] (Pubitemid 47230635)
18. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561-574 [PMID: 15163405 DOI: 10.1016/j.cell.2004.05.004] (Pubitemid 38692523)
19. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27: 229-265 [PMID: 19302040 DOI: 10.1146/annurev.immunol.021908.132715]
20. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011; 54: 133-144 [PMID: 21488066 DOI: 10.1002/hep.24341]
21. Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010; 52: 934-944 [PMID: 20607689 DOI: 10.1002/hep.23797]
22. Velayudham A, Hritz I, Dolganiuc A, Mandrekar P, Kurt-Jones E, Szabo G. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. J Hepatol 2006; 45: 813-824 [PMID: 16935388 DOI: 10.1016/j.jhep.2006.06.017] (Pubitemid 44646677)
23. Schattenberg JM, Galle PR. Animal models of non-alcoholic steatohepatitis: of mice and man. Dig Dis 2010; 28: 247-254 [PMID: 20460919 DOI: 10.1159/000282097]
24. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16 [PMID: 15508102] (Pubitemid 39423365)
25. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121-124 [PMID: 17615358 DOI: 10.1126/science.1140485] (Pubitemid 47056470)
26. Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 1993; 53: 790-794 [PMID: 8381328]
27. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol 2001; 34: 730-739 [PMID: 11434620] (Pubitemid 32488789)
28. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127 [PMID: 21992124 DOI: 10.1056/NEJMra1001683]
29. Kim WR, Poterucha JJ, Benson JT, Therneau TM. The impact of competing risks on the observed rate of chronic hepatitis C progression. Gastroenterology 2004; 127: 749-755 [PMID: 15362031] (Pubitemid 39208408)
30. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, van den Berg S, Romijn J, Rensen PC, Joosten LA, Netea MG, Kanneganti TD. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA 2011; 108: 15324-15329 [PMID: 21876127 DOI: 10.1073/pnas.1100255108]
31. Savard C, Tartaglione EV, Kuver R, Haigh WG, Farrell GC, Subramanian S, Chait A, Yeh MM, Quinn LS, Ioannou GN. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology 2013; 57: 81-92 [PMID: 22508243 DOI: 10.1002/hep.25789]
32. Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18: 2300-2308 [PMID: 22654421 DOI: 10.3748/wjg.v18.i19.2300]
33. Almonacid-Urrego CC, Sánchez-Campos S, Tuñón MJ, González-Gallego J. Non-alcoholic steatohepatitis: what can we learn from animal models? Curr Med Chem 2012; 19: 1389-1404 [PMID: 22360487]
34. Csak T, Dolganiuc A, Kodys K, Nath B, Petrasek J, Bala S, Lippai D, Szabo G. Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice. Hepatology 2011; 53: 1917-1931 [PMID: 21425308 DOI: 10.1002/hep.24301]
35. Gäbele E, Dostert K, Dorn C, Patsenker E, Stickel F, Hellerbrand C. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcohol Clin Exp Res 2011; 35: 1361-1367 [PMID: 21463337 DOI: 10.1111/j.1530-0277.2011.01472.x]
36. Xu ZJ, Fan JG, Ding XD, Qiao L, Wang GL. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig Dis Sci 2010; 55: 931-940 [PMID: 19459046 DOI: 10.1007/s10620-009-0815-3]
37. Ito M, Suzuki J, Tsujioka S, Sasaki M, Gomori A, Shirakura T, Hirose H, Ito M, Ishihara A, Iwaasa H, Kanatani A. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol Res 2007; 37: 50-57 [PMID: 17300698 DOI: 10.1111/j.1872-034X.2007.00008.x] (Pubitemid 46403840)